FMN2 and acute lymphoblastic leukemia: Further assays showed that the upregulation of miR-144 via the downregulation of its target human formin-2 (FMN2) suppressed proliferation and cell-cycle transition of ALL cells, whereas the miR-144 downregulation did not affect ALL progress [50].